Archives
2024 Chicago Cholangiocarcinoma Symposium
The 2024 Chicago Cholangiocarcinoma Symposium is set to convene in Chicago, drawing together leading experts, researchers, healthcare professionals, patients, and…
A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors
Study Name A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors…
Peggy Newland
12/19/1967-9/22/2021 On September 22, 2021, a cherished daughter, sister, mother, and grandmother, lost a courageous battle with cancer ( a…
Webinar: Personalizing cancer treatments with the PARIS® Test for cholangiocarcinoma patients
Subscribe to our YouTube Channel Title: Personalizing cancer treatments with the PARIS® Test for cholangiocarcinoma patients Recorded: Thurs., Sept. 23,…
Patient Support Group
Each week we present the latest information and updates relevant to the CCF community. Support Groups will be held the…
Giving Thanks by Giving Back
Help us meet our goal of 100 new sign-ups by 2021! Join the CCF registry through Ciitizen to advance research…
Webinar: NuTide 121 Clinical Trial
Home / Blog / [wpbb post:title] NuCana will introduce the science behind NUC-1031, the medicine being compared in combination with…
Webinar: The RELEASE trial and the technology behind
Subscribe to our YouTube Channel This webinar is intended for patients with inoperable extrahepatic cholangiocarcinoma (CCA) who consider enrolment into…
FB Live: Living with Cholangiocarcinoma - Journey to Diagnosis & Beyond
Watch Recorded Event on Facebook Watch our Facebook Live event, "Living with Cholangiocarcinoma - Journey to Diagnosis & Beyond." …
Biomarker reveals how aggressive biliary tract cancer is in patients
Home / Blog / [wpbb post:title] From Jesper Anderson at the University of Copenhagen... As biliary tract cancer (BTC) patients…